CAIRO, Stefano Enrico
 Distribuzione geografica
Continente #
NA - Nord America 2.961
AS - Asia 1.370
EU - Europa 592
SA - Sud America 327
AF - Africa 46
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.299
Nazione #
US - Stati Uniti d'America 2.901
SG - Singapore 584
CN - Cina 360
BR - Brasile 290
HK - Hong Kong 148
DE - Germania 117
UA - Ucraina 98
SE - Svezia 84
GB - Regno Unito 78
TR - Turchia 77
VN - Vietnam 67
IT - Italia 64
RU - Federazione Russa 39
FI - Finlandia 34
MX - Messico 30
CA - Canada 27
ID - Indonesia 24
BD - Bangladesh 19
IN - India 19
ZA - Sudafrica 19
JP - Giappone 17
FR - Francia 16
AR - Argentina 14
ES - Italia 12
MA - Marocco 12
PL - Polonia 12
NL - Olanda 9
AT - Austria 8
EC - Ecuador 8
IR - Iran 8
PK - Pakistan 8
CZ - Repubblica Ceca 7
KR - Corea 7
CO - Colombia 6
IL - Israele 4
IQ - Iraq 4
LT - Lituania 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
BE - Belgio 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
EG - Egitto 3
JO - Giordania 3
KE - Kenya 3
NP - Nepal 3
VE - Venezuela 3
KG - Kirghizistan 2
MG - Madagascar 2
RS - Serbia 2
SA - Arabia Saudita 2
SN - Senegal 2
TW - Taiwan 2
UY - Uruguay 2
AL - Albania 1
AU - Australia 1
BF - Burkina Faso 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
CL - Cile 1
EU - Europa 1
KI - Kiribati 1
LB - Libano 1
MD - Moldavia 1
OM - Oman 1
PE - Perù 1
PS - Palestinian Territory 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
TL - Timor Orientale 1
TN - Tunisia 1
Totale 5.299
Città #
Fairfield 322
Singapore 303
Ashburn 298
Woodbridge 286
Chandler 157
Houston 157
Santa Clara 149
Beijing 148
Hong Kong 144
Jacksonville 132
Seattle 129
Ann Arbor 126
Wilmington 121
Cambridge 102
New York 73
Dallas 70
Los Angeles 48
Izmir 47
Nanjing 37
Boardman 36
Dearborn 35
Princeton 29
Shanghai 27
São Paulo 26
Ho Chi Minh City 25
Ferrara 22
Mexico City 22
Bremen 20
San Diego 19
Jakarta 17
Montreal 17
Tokyo 17
Falls Church 16
Munich 15
Brooklyn 14
Chicago 14
Hanoi 14
London 14
The Dalles 14
Augusta 13
Nanchang 13
Phoenix 12
Stockholm 12
Warsaw 11
Hebei 10
Rio de Janeiro 10
San Francisco 10
Ankara 9
Johannesburg 9
Moscow 9
Atlanta 8
Chennai 8
Columbus 8
Council Bluffs 8
Curitiba 8
Guangzhou 8
Manchester 8
Nuremberg 8
Poplar 8
Shenyang 8
Boston 7
Des Moines 7
Jiaxing 7
Ardabil 6
Campinas 6
Denver 6
Hangzhou 6
Milan 6
Norwalk 6
San Jose 6
Addison 5
Belo Horizonte 5
Changsha 5
Fes 5
Guarulhos 5
Orem 5
Redwood City 5
Amsterdam 4
Biên Hòa 4
Brasília 4
Brno 4
Casalecchio Di Reno 4
Charlotte 4
Da Nang 4
Haiphong 4
Hefei 4
Leawood 4
Mountain View 4
Orange 4
Osasco 4
San Mateo 4
Seoul 4
São Gonçalo 4
Tashkent 4
Tianjin 4
Toronto 4
Três Corações 4
Amman 3
Auburn Hills 3
Brussels 3
Totale 3.647
Nome #
Abstract P5-06-04: The PARP inhibitor niraparib demonstrated activity in patient-derived triple-negative breast cancer xenograft models with high homologous recombination deficiency (HRD) score 219
Early activation of IFN/STAT signaling in tumor cells of patient-derived triple negative breast cancer xenografts predicts tumor sensitivity to chemotherapy 206
Activation of Wnt and Myc signaling in hepatoblastoma 194
Reprogramming of miRNA networks in cancer and leukemia 191
Functional genomics of the B-box gene family reveals a possible role in subcellular compartmentalization 189
Functional characterization of the OFD1 protein reveals a nuclear localization and physical interaction with subunits of a chromatin remodeling complex 187
Deficiency of multidrug resistance 2 contributes to cell transformation through oxidative stress 182
CA3-Classification de l’hépatoblastome par l'étude en microarray du profil d’expression génétique 182
Mlx, a new Max-like bHLHZip family member: the center stage of a novel transcription factors regulatory pathway? 180
Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer 180
The genomic landscape of hepatoblastoma and their progenies with HCC-like features 169
How transient becomes stable: an epigenetic switch linking liver inflammation and tumorigenesis 168
PML interacts with Myc, and Myc target gene expression is altered in PML-null fibroblasts 165
Heterogeneous expression of EPCAM in human circulating tumour cells from patient-derived xenografts 164
Preferential localization of tyrosine-phosphorylated paxillin in focal adhesions 155
TAK1 suppresses a NEMO-dependent but NF-kappaB-independent pathway to liver cancer 153
The MET Inhibitor AZD6094 (Savolitinib, HMPL-504) induces regression in papillary renal cell carcinoma patient-derived xenograft models 151
The four and a half LIM-only protein 2 regulates liver homeostasis and contributes to carcinogenesis 150
The tripartite motif family identifies cell compartments 149
LIM-only protein FHL2 activates NF-κB signaling in the control of liver regeneration and hepatocarcinogenesis 149
The hepatitis B virus X protein functionally interacts with CREB-binding protein/p300 in the regulation of CREB-mediated transcription 144
Myc target miRs and liver cancer: small molecules to get Myc sick 140
Hepatic Stem-like Phenotype and Interplay of Wnt/β-Catenin and Myc Signaling in Aggressive Childhood Liver Cancer 135
Subset of Suz12/PRC2 target genes is activated during hepatitis B virus replication and liver carcinogenesis associated with HBV X protein 132
The sialyl-glycolipid stage-specific embryonic antigen 4 marks a subpopulation of chemotherapy-resistant breast cancer cells with mesenchymal features 130
Activation of IFN/STAT1 signalling predicts response to chemotherapy in oestrogen receptor-negative breast cancer 99
Patient-derived xenografts from pediatric liver cancer predict tumor recurrence and advise clinical management 92
Targeting the Vav1/miR‐29b axis as a potential approach for treating selected molecular subtypes of triple‐negative breast cancer 87
A KRAS-responsive long non-coding RNA controls microRNA processing 86
null 83
Abstract B11: A panel of patient-derived xenografts for preclinical efficacy studies in various breast cancer molecular subtypes 80
null 76
Genomic analysis of the TRIM family reveals two groups of genes with distinct evolutionary properties 69
Expression profiling and CGH array as prognostic tools in hepatoblastoma 67
Functional evaluation of interferon/STAT1 pathway activation in response to genotoxic treatment 65
Establishment and characterization of circulating tumor cell-derived xenografts in non-small cell lung cancer 61
A panel of pediatric liver cancer patient-derived xenografts to improve stratification of children with hepatoblastoma 59
SSEA4 AND ST3GAL2 AS CHEMOTHERAPEUTIC DRUG RESPONSE BIOMARKERS 57
Vav1 Selectively Down-Regulates Akt2 through miR-29b in Certain Breast Tumors with Triple Negative Phenotype 50
The PARP inhibitor niraparib demonstrates robust activity in a subset of patient-derived triple-negative breast cancer xenograft models 37
Wnt signaling and hepatocarcinogenesis: The hepatoblastoma model 34
Tbx3 is a downstream target of the Wnt/$\beta$-catenin pathway and a critical mediator of $\beta$-catenin survival functions in liver cancer 34
Polo-like kinase 1 inhibition suppresses hepatitis B virus X protein-induced transformation in an in vitro model of liver cancer progression 32
Preclinical evaluation of the PARP inhibitor niraparib and cytotoxic chemotherapy alone or in combination in a panel of 25 triple-negative breast cancer PDX models: Relevance of BRCA mutations, HRD status and other biomarkers 30
Understanding breast cancer resistance to chemotherapy: Characterization of cancer cell sub-populations in residual and relapsed tumors 29
Totale 5.391
Categoria #
all - tutte 27.488
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.488


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021272 0 0 0 0 0 46 11 49 11 44 79 32
2021/2022313 20 21 16 7 31 30 12 26 11 38 33 68
2022/2023361 30 33 27 36 70 45 11 29 43 5 20 12
2023/2024231 14 26 7 6 7 52 5 19 6 10 7 72
2024/2025960 21 14 60 20 124 72 61 72 167 94 171 84
2025/20261.483 265 113 247 280 449 129 0 0 0 0 0 0
Totale 5.391